BIOLOGICAL DRUGS USE

Brand Owner Address Description
CYTOMX CytomX Therapeutics, Inc. 151 Oyster Point Blvd, Suite 400 South San Francisco CA 94080 Biological drugs for use in treating cancer, and autoimmunity; therapeutic and medical diagnostic agents and preparations for use in therapies and diagnosis for cancer, and autoimmunity; biochemicals, immunoglobulins and antigen-binding fragments for use in therapies and medical diagnosis for cancer, and autoimmunity; therapeutic and diagnostic agents, preparations and substances for medical purposes for targeting application to immune system, cells, or genes; immune modulators, immunoglobulin drug conjugates, immunotherapies and therapeutic and diagnostic agents, preparations and substances in the field of dysregulated proteolytic activity for medical purposes; immunotherapies and therapeutic and medical diagnostic agents, preparations and substances in the field of cancer, and autoimmunity for medical purposes;
 

Where the owner name is not linked, that owner no longer owns the brand

    
Technical Examples
  1. Medical devices, and in particular implantable medical devices, may be coated to minimize or substantially eliminate a biological organism's reaction to the introduction of the medical device to the organism. The medical devices may be coated with any number of biocompatible materials. Therapeutic drugs, agents or compounds may be mixed with the biocompatible materials and affixed to at least a portion of the medical device. In addition to reducing or substantially eliminating a biological organism's reaction to the introduction of the medical device to the organism, the medical device in combination with one or more therapeutic drugs, agents and/or compounds may be utilized to treat various vascular diseases, for example, restenosis and vulnerable plaque. In the case of vulnerable plaque, one or more drugs, agents or compounds may be utilized to treat the various aspects of vulnerable plaque and these drugs, agents and/or compounds may be released with a given release profile for the most effective treatment. Various materials and coating methodologies may be utilized to maintain the drugs, agents or compounds on the medical device until delivered and positioned.